Clinical trial
A Study of Isoprinosine in Patients With Lymph Node Disease
NCT00002297 · Newport Pharmaceuticals International, Industry · Completed
Key facts
| NCT number | NCT00002297 |
|---|---|
| Title | A Study of Isoprinosine in Patients With Lymph Node Disease |
| Official title | A Multi-Center Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Unexplained Generalized Lymphadenopathy |
| Lead sponsor | Newport Pharmaceuticals International, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphatic Disease, HIV Infections |
| Intervention type | Drug |
| Interventions | Inosine pranobex |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: